TxCell SA , a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China. Miguel Forte was invited to present, and will be hosted during the event, by Ferring International Center .
http://ift.tt/1sNdRcl
http://ift.tt/1sNdRcl
No comments:
Post a Comment